Capital Expenditures - HitGen Inc (SSE:688222) - Alpha Spread

HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 8.65 CNY 2.13% Market Closed
Market Cap: 3.5B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HitGen Inc
Capital Expenditures Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Capital Expenditures
-ÂĄ53.7m
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Capital Expenditures
-ÂĄ4.6B
CAGR 3-Years
0%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Capital Expenditures
-ÂĄ2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Capital Expenditures
-ÂĄ4.2B
CAGR 3-Years
16%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Capital Expenditures
-ÂĄ359m
CAGR 3-Years
-8%
CAGR 5-Years
-31%
CAGR 10-Years
-25%
Genscript Biotech Corp
HKEX:1548
Capital Expenditures
-$177.1m
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
N/A

See Also

What is HitGen Inc's Capital Expenditures?
Capital Expenditures
-53.7m CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Capital Expenditures amounts to -53.7m CNY.

What is HitGen Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
6%

Over the last year, the Capital Expenditures growth was 38%. The average annual Capital Expenditures growth rates for HitGen Inc have been 13% over the past three years , 6% over the past five years .

Back to Top